Table 1. Subject characteristics.
| Variables | N = 191 |
|---|---|
| Age, median [IQR] | 42 [28] |
| Serum 25(OH) D level, median [IQR], in ng/mL | 13.6 [10.98] |
| Sex, N (%) | |
| Female | 104 (54.5) |
| Male | 87 (45.5) |
| Body mass index (BMI), median [IQR] | 22.66 [4.13] |
| COVID-19 categories, n (%) | |
| Mild | 93 (48.7) |
| Moderate | 67 (35.1) |
| Severe – critical | 31 (16.2) |
| Number of comorbid, N (%) | |
| None | 72 (37.7) |
| 1 | 40 (20.9) |
| 2 | 79 (41.4) |
| Type of comorbidities | |
| Type 2 DM, N (%) | 63 (32.9) |
| Hypertension, N (%) | 60 (31.5) |
| Cardiovascular disease, N (%) | 17 (8.9) |
| Chronic liver disease, N (%) | 6 (3.2) |
| Chronic kidney failure, N (%) | 19 (9.9) |
| Cerebrovascular disease, N (%) | 12 (6.3) |
| Malignancy, N (%) | 19 (9.9) |
| HIV, N (%) | 1 (0.6) |
| Autoimmune diseases, N (%) | 10 (5.2) |
| COPD, N (%) | 2 (1.1) |
| Vaccination status, n (%) | |
| Unvaccinated | 60 (31.5) |
| One dose | 2 (1) |
| Two doses | 128 (67.1) |
| Three doses | 1 (0.5) |
| Simple oxygenation, n (%) | 61 (31.9) |
| ISARIC-4C Score, N (%) | |
| 1 (Low risk) | 109 (57) |
| 2 (Intermediate risk) | 39 (20.4) |
| 3 (High risk) | 31 (16.2) |
| 4 (Very high risk) | 12 (6.3) |
Abbreviations: COPD, chronic obstructive pulmonary disease; Type 2 DM, Type 2 Diabetes Mellitus.